Testing effectiveness (Phase 2)Study completedNCT00043407What this trial is testingCPG 7909 in Patients Wih Stage IV Renal Cell CancerWho this might be right forCarcinoma, Renal Cell Pfizer 42
Testing effectiveness (Phase 2)Study completedNCT00617253What this trial is testingCombination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma PatientsWho this might be right forCancerRenal Cell Carcinoma Novo Nordisk A/S 9
Not applicableStudy completedNCT05025748What this trial is testingAsk Questions (ASQ):Implementation of a Communication InterventionWho this might be right forStage II Breast CancerStage III Breast CancerStage IV Breast Cancer+20 more Barbara Ann Karmanos Cancer Institute 81
Testing effectiveness (Phase 2)Ended earlyNCT00704938What this trial is testingGene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerWho this might be right forKidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 3
Large-scale testing (Phase 3)Study completedNCT00002737What this trial is testingInterferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC 320
Early research (Phase 1)Ended earlyNCT00623077What this trial is testingMT2004-30: Tomotherapy for Solid TumorsWho this might be right forBrain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more Masonic Cancer Center, University of Minnesota 23
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Testing effectiveness (Phase 2)Study completedNCT00003091What this trial is testingHigh-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaWho this might be right forKidney CancerMelanoma (Skin) Hoag Memorial Hospital Presbyterian 40
Not applicableStudy completedNCT00617799What this trial is testingBiomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaWho this might be right forKidney CancerMelanoma (Skin) University of Nebraska 15
Testing effectiveness (Phase 2)Ended earlyNCT04398368What this trial is testingGemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI StudyWho this might be right forStage 0a Renal Pelvis and Ureter Cancer AJCC v8Stage 0a Renal Pelvis Cancer AJCC v8Stage 0a Ureter Cancer AJCC v8+15 more Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT01835158What this trial is testingCabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 157
Early research (Phase 1)UnknownNCT00016042What this trial is testingFluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal CancerWho this might be right forColorectal CancerKidney Cancer St. Luke's Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03092856What this trial is testingAxitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+1 more University of Southern California 62
Testing effectiveness (Phase 2)Study completedNCT00039429What this trial is testingAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group 180
Early research (Phase 1)Study completedNCT01061411What this trial is testingDalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more Roswell Park Cancer Institute 16
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00085436What this trial is testingDC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCCWho this might be right forKidney Cancer Dartmouth-Hitchcock Medical Center 18
Not applicableLooking for participantsNCT05837767What this trial is testingRadiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueWho this might be right forInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT03274258What this trial is testingPhase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary CarcinomaWho this might be right forKidney Medullary CarcinomaLoss of INI 1 Protein ExpressionStage III Renal Cell Cancer AJCC v8+1 more M.D. Anderson Cancer Center 10